JMKX000189

· Jemincare

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JMKX000189, covering 2023-10-13 to 2023-10-13. Get the full timeline:

Most recent: Clinical Trial Update: JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus [Phase 2]